Related Experiment Video

Updated: Aug 7, 2026

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
06:34

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography

Published on: October 28, 2020

[Relation of left ventricular mass and QT dispersion in patients with essential hypertension]

Z Pei1, S Zhang

  • 1Department of Cardiology, Xiangya Hospital, Hunan Medical University, Changsha 410008.

Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University
|June 26, 2002
PubMed

Insights

Left ventricular hypertrophy (LVH) significantly increases rate-corrected QT interval dispersion (QTcd), indicating a higher risk of cardiac issues. This effect is linked to increased left ventricular mass, not blood pressure in hypertensive patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Hypertension Research

Context:

  • Essential hypertension is a significant risk factor for cardiovascular disease.
  • Left ventricular hypertrophy (LVH) is a common complication of hypertension.
  • QT interval dispersion (QTcd) is a marker of cardiac electrical instability.

Purpose:

  • To investigate the relationship between left ventricular mass and rate-corrected QT interval dispersion (QTcd) in patients with essential hypertension.
  • To determine if LVH or blood pressure is the primary driver of QTcd changes.

Summary:

  • In 79 hypertensive patients, QTcd and QTcd% were significantly higher in the LVH group compared to the non-LVH group.
  • A positive correlation was observed between left ventricular mass index (LVMI) and QTcd (r=0.7720) and QTcd% (r=0.6798).
  • Blood pressure was not associated with QTcd, suggesting LVH is the key factor influencing QTcd.

Impact:

  • The findings suggest that LVH, rather than hypertension itself, is the primary determinant of increased QTcd.
  • This highlights the importance of assessing LVH in hypertensive patients for risk stratification.
  • Understanding the link between LVH and QTcd may lead to improved management strategies for hypertensive cardiovascular complications.

More Related Videos

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease08:57

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease

Published on: May 22, 2026

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...